About Us
Arkuda is comprised of passionate and experienced team members who are dedicated to improving the lives of people affected by neurodegenerative disease. Armed with deep expertise in biology and the ability to understand the root cause of disease, we are discovering medicines with the potential to positively change the trajectory of neurodegeneration.
Duane Burnett, PhD,
Chief Technology Officer
GERHARD KOENIG, PHD,
Co-founder, President and CEO
Betsy Kassler,
Senior Director, Human Resources
Raymond Hurst, PhD,
Senior Vice President, Discovery
Mike Esposito, MSF,
Vice President, Finance
Anna-Maria Alves, MS,
Associate Scientist
Jean-François Blain, PhD,
Vice President, Neurobiology
Angela Chen, MS,
Scientist II
Veronika Heil,
Associate Scientist
Shawna Henry, PhD,
Scientist I
Christopher Holler, PhD,
Principal Scientist
Deliwe Jalbert, MBA,
Executive Assistant
Jim Lanter, PhD,
Vice President, Medicinal Chemistry
Ingrid Ochoa,
Lab/Facility Manager
Denise Peters,
Accounting Controller
John Ross, MS, RLATG, DSP, DABT,
Associate Director, Toxicology
Mary Wozniak,
Senior Research Associate
